作者：
Hughes,T.P. [1]
;
Hochhaus,A. [2]
;
Kantarjian,H.M. [3]
;
Cervantes,F. [4]
;
Guilhot,F. [5]
;
Niederwieser,D. [6]
;
LeCoutre,P.D. [7]
;
Rosti,G. [8]
;
Ossenkoppele,G. [9]
;
Lobo,C. [10]
;
Shibayama,H. [11]
;
Fan,X. [12]
;
Menssen,H.D. [13]
;
Kemp,C. [14]
;
Larson,R.A. [15]
;
Saglio,G.
作者单位：
Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
[1]
Inserm CIC 0802, CHU de Poitiers, France
[2]
Division of Hematology and Oncology, University of Leipzig, Germany
[3]
South Australian Health and Medical Research Institute, University of Adelaide, Australia, Division
[4]
VU University Medical Center, Amsterdam, Netherlands
[5]
Charité - Universit?tsmedizin Berlin, Germany
[6]
Novartis Pharma AG, Basel, Switzerland
[7]
Osaka University Graduate School of Medicine, Osaka, Japan
[8]
IDIBAPS, University of Barcelona, Spain
[9]
University of Turin, Orbassano, Italy
[10]
Abteilung H?matologie/Onkologie, Universit?tsklinikum Jena, Germany
[11]
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
[12]
HEMORIO, Rio de Janeiro, Brazil
[13]
The University of Chicago, IL, United States
[14]
University of Bologna, Italy
[15]
发布时间
2014-12-13
换一批
